NCT03792139View on ClinicalTrials.gov

An Interaction Study of LY3200882 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 8, 2019

Primary Completion Date

February 23, 2019

Study Completion Date

February 23, 2019

Conditions
Healthy
Interventions
DRUG

LY3200882

Administered orally.

DRUG

Itraconazole

Administered orally.

Trial Locations (1)

32117

Covance Clinical Research Inc, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03792139 - An Interaction Study of LY3200882 in Healthy Participants | Biotech Hunter | Biotech Hunter